No Reported Revenue

Pre-revenue companies are focused on product development, user acquisition, or market validation before monetization. This is common for deep-tech, biotech, and platform companies that need to build critical mass before turning on revenue. For angel investors, pre-revenue investments carry higher risk but offer the lowest entry prices. This group lists every company without a published revenue figure, so it also includes companies that simply do not disclose revenue.

Companies201

Total Funding$49.8B

Avg Value$12.2B

Markets33

Criteria

No meaningful recurring revenue
May have pilot customers or LOIs
Product still in development or beta
Business model may still be evolving

Implications for Investors

Highest risk category
Lowest entry prices
Longer time to liquidity
Follow-on funding essential

Market Distribution

AI / ML51
Robotics17
Cleantech15
Hardware13
Finance11
Aerospace8
Biotech8
Investment Platforms7
Blockchain / Crypto6
SaaS6

Value Distribution

<$100M87
$100M-$500M42
$500M-$1B14
$1B-$10B34
$10B+8

Frequently Asked Questions

Is it risky to invest in pre-revenue companies?

Yes, pre-revenue investments are the highest risk. However, they also offer the lowest entry prices and highest potential multiples. The key is evaluating the team, market size, and product differentiation.

How long do companies typically stay pre-revenue?

Most software startups generate first revenue within 6-18 months. Deep-tech and biotech companies may be pre-revenue for 3-7+ years. Hardware companies typically take 12-24 months.

What should I look for in a pre-revenue company?

Strong founding team with domain expertise, large addressable market, unique technology or insight, early user engagement (even without revenue), and a clear path to monetization.